HOME › DRUGS › DURVALUMAB
ACTIVE SUBSTANCE / INN

DURVALUMAB

Brand name(s): IMFINZI, Imfinzi
FDA LISTED
EMA LISTED
PRESCRIPTION
AUTHORISED
BLA761069
Carcinoma, Non-Small-Cell Lung
ACTIVE SUBSTANCE
Durvalumab
REGULATORS
FDA · EMA
SPONSORS / MAH
ASTRAZENECA UK LTD, AstraZeneca AB
TOTAL APPLICATIONS
2
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
IMFINZIBLA761069ASTRAZENECA UK LTDPrescription
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
ImfinziAstraZeneca ABAuthorised21/09/2018Carcinoma, Non-Small-Cell Lung

FULL INTELLIGENCE ON DURVALUMAB

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →